n-methylaspartate has been researched along with Chronic Primary Open Angle Glaucoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdelsaid, MA; Baldowski, BR; Bollinger, KE; El-Azab, MF; El-Remessy, AB; Matragoon, S; Mohamed, IN; Mysona, BA; Saul, A; Shanab, AY | 1 |
Braunger, BM; Fuchshofer, R; Gallenberger, M; Iwata, T; Koch, M; Kroeber, M; März, L; Tamm, ER | 1 |
Danesh-Meyer, HV; Levin, LA | 1 |
Chan, HH; Chu, PH; Ho, WC; Lung, JC; Ng, YF; So, KF; Ting, PW; To, CH | 1 |
Bahrani, HM; Dorotheo, EU; Frishman, LJ; Rangaswamy, NV; Schiffman, JS; Tang, RA | 1 |
Ahmed, J; Frishman, L; Greenstein, V; Holopigian, K; Hood, DC; Robson, JG; Seiple, W; Viswanathan, S | 1 |
Burakgazi, E; Chalmers-Redman, R; Danias, J; Mittag, TW; Podos, SM; Pohorenec, G; Tatton, WG; Yuan, HM | 1 |
1 review(s) available for n-methylaspartate and Chronic Primary Open Angle Glaucoma
Article | Year |
---|---|
Neuroprotection: extrapolating from neurologic diseases to the eye.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Endpoint Determination; Excitatory Amino Acid Antagonists; Glaucoma, Open-Angle; Humans; Memantine; N-Methylaspartate; Nervous System Diseases; Neuroprotective Agents; Optic Nerve Diseases; Riluzole | 2009 |
6 other study(ies) available for n-methylaspartate and Chronic Primary Open Angle Glaucoma
Article | Year |
---|---|
Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury.
Topics: Adult; Aged; Animals; Apoptosis; Carrier Proteins; Cells, Cultured; Ependymoglial Cells; Female; Glaucoma, Open-Angle; Humans; Inflammation; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; N-Methylaspartate; Neurotoxicity Syndromes; Retina; Thioredoxin-Disulfide Reductase; Thioredoxins; Tumor Necrosis Factor-alpha; Tyrosine; Vascular System Injuries | 2014 |
Heterozygote Wdr36-deficient mice do not develop glaucoma.
Topics: Alleles; Animals; Axons; Blotting, Northern; Disease Models, Animal; Eye Proteins; Gene Expression Regulation; Glaucoma, Open-Angle; Intraocular Pressure; Loss of Heterozygosity; Mice; Mice, Inbred C57BL; Mice, Transgenic; N-Methylaspartate; Optic Nerve Diseases; Phenotype; Real-Time Polymerase Chain Reaction; Retinal Ganglion Cells; Risk Factors; RNA, Messenger; Tonometry, Ocular | 2014 |
Effect of inner retinal dysfunction on slow double-stimulation multifocal electroretinogram.
Topics: Adaptation, Physiological; Adult; Animals; Case-Control Studies; Disease Models, Animal; Early Diagnosis; Electroretinography; Gerbillinae; Glaucoma, Open-Angle; Humans; Middle Aged; N-Methylaspartate; Photic Stimulation; Retina; Retinal Diseases; Tetrodotoxin; Visual Fields | 2011 |
Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina.
Topics: Adult; Aged; Animals; Electroretinography; Female; Glaucoma, Open-Angle; Humans; Light; Macaca mulatta; Male; Middle Aged; N-Methylaspartate; Nerve Compression Syndromes; Optic Nerve Diseases; Optic Neuropathy, Ischemic; Photic Stimulation; Pipecolic Acids; Retina; Tetrodotoxin | 2004 |
Identifying inner retinal contributions to the human multifocal ERG.
Topics: Adult; Animals; Diabetic Retinopathy; Electroretinography; Glaucoma, Open-Angle; Humans; Macaca mulatta; Middle Aged; N-Methylaspartate; Pattern Recognition, Visual; Retina; Retinal Ganglion Cells; Tetrodotoxin | 1999 |
Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
Topics: Animals; Cell Death; Cell Nucleus; Disease Models, Animal; DNA Fragmentation; Electroretinography; Female; Fluorescent Dyes; Glaucoma, Open-Angle; Intraocular Pressure; Membrane Potentials; Microscopy, Confocal; Microscopy, Fluorescence; Mitochondria; N-Methylaspartate; Rats; Rats, Wistar; Retinal Diseases; Retinal Ganglion Cells; Stilbamidines; Time Factors | 2000 |